Wafik Saad El-Bardissy
Chief Executive Officer bei MINAPHARM PHARMACEUTICALS
Vermögen: 7 Mio $ am 31.03.2024
Profil
Wafik Saad El-Bardissy is currently the Chairman-Supervisory Board at ProBioGen AG and the Chairman & Co-Managing Director at Minapharm Pharmaceuticals.
He was previously a Member-Management Board at Rentschler Biopharma SE.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
MINAPHARM PHARMACEUTICALS
10,89% | 30.09.2022 | 1 338 244 ( 10,89% ) | 7 Mio $ | 31.03.2024 |
Aktive Positionen von Wafik Saad El-Bardissy
Unternehmen | Position | Beginn |
---|---|---|
MINAPHARM PHARMACEUTICALS | Chief Executive Officer | 19.10.2010 |
ProBioGen AG
ProBioGen AG Miscellaneous Commercial ServicesCommercial Services ProBioGen AG operates as a contract development and manufacturing organization. It specializes in cell line engineering, process development, and GMP manufacturing of biopharmaceuticals. The firm offers services such as cell line development, process development, manufacturing programs, physio-chemical analyses, and cell-based assays. The company was founded by Uwe Marx on June 13, 1994 and is headquartered in Berlin, Germany. | Chairman | 18.06.2010 |
Ehemalige bekannte Positionen von Wafik Saad El-Bardissy
Unternehmen | Position | Ende |
---|---|---|
Rentschler Biopharma SE
Rentschler Biopharma SE Pharmaceuticals: MajorHealth Technology Rentschler Biopharma SE develops and produces pharmaceutical products. Its solutions include bioprocess development, bio manufacturing, associated consulting activities including cell line process, cell culture, aseptic filling, consulting, planning and project management services. The company was founded in 1927 and is headquartered in Laupheim, Germany. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MINAPHARM PHARMACEUTICALS | Health Technology |
Private Unternehmen | 2 |
---|---|
ProBioGen AG
ProBioGen AG Miscellaneous Commercial ServicesCommercial Services ProBioGen AG operates as a contract development and manufacturing organization. It specializes in cell line engineering, process development, and GMP manufacturing of biopharmaceuticals. The firm offers services such as cell line development, process development, manufacturing programs, physio-chemical analyses, and cell-based assays. The company was founded by Uwe Marx on June 13, 1994 and is headquartered in Berlin, Germany. | Commercial Services |
Rentschler Biopharma SE
Rentschler Biopharma SE Pharmaceuticals: MajorHealth Technology Rentschler Biopharma SE develops and produces pharmaceutical products. Its solutions include bioprocess development, bio manufacturing, associated consulting activities including cell line process, cell culture, aseptic filling, consulting, planning and project management services. The company was founded in 1927 and is headquartered in Laupheim, Germany. | Health Technology |